Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Revenue

In the year 2023, Adaptive Biotechnologies had annual revenue of $170.28M, a decrease of -8.11%. Revenue in the quarter ending December 31, 2023 was $45.78M, a -17.05% decrease year-over-year.

• Revenue (ttm): $170.28M
• Revenue Growth: -8.11%
• P/S Ratio: 2.61
• Revenue / Employee: $240,164
• Employees: 709
• Market Cap: 443.58M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	170.28M	-15.03M	-8.11%
Dec 31, 2022	185.31M	30.96M	20.06%
Dec 31, 2021	154.34M	55.96M	56.88%
Dec 31, 2020	98.38M	13.31M	15.65%
Dec 31, 2019	85.07M	29.41M	52.83%
Dec 31, 2018	55.66M	17.22M	44.77%
Dec 31, 2017	38.45M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.